Quick Takeaways
- Jeffrey A. Meckler filed SCHEDULE 13D/A for Indaptus Therapeutics, Inc. Common Stock, $0.01 par value per share (INDP).
- Disclosed ownership: 13%.
- Date of event: 22 Dec 2025.
Jeffrey A. Meckler - 22 Dec 2025 SCHEDULE 13D/A Report for Indaptus Therapeutics, Inc. Common Stock, $0.01 par value per share (INDP)
- Filing Manager
- Jeffrey A. Meckler
- Reporting Manager
- Jeffery A. Meckler
- Symbol
- INDP
- Shares outstanding
- 2,150,417 shares
- Disclosed Ownership
- 273,103 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13D/A
- Filing time
- 30 Dec 2025, 16:01:09 UTC
- Date of event
- 22 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jeffrey A. Meckler disclosed 13% ownership in Indaptus Therapeutics, Inc. Common Stock, $0.01 par value per share (INDP) on 22 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Dec 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Jeffery A. Meckler | 13% | 273,103 | 273,103 | 0 | /s/ Jeffery A. Meckler | Jeffery A. Meckler | 0001506916 |